An exploratory analysis of alkaline phosphatase, lactate dehydrogenase, and prostate-specific antigen dynamics in the phase 3 ALSYMPCA trial with radium-223-Reference-Cited by-同舟云学术

An exploratory analysis of alkaline phosphatase, lactate dehydrogenase, and prostate-specific antigen dynamics in the phase 3 ALSYMPCA trial with radium-223

Published:2017-05 Issue:5 Volume:28 Page:1090-1097
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Sartor O.,Coleman R.E.,Nilsson S.,Heinrich D.,Helle S.I.,O’Sullivan J.M.,Vogelzang N.J.,Bruland Ø.,Kobina S.,Wilhelm S.,Xu L.,Shan M.,Kattan M.W.,Parker C.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/28/5/1090/24169364/mdx044.pdf

Reference23 articles.

1. Nomogram for overall survival of patients with progressive metastatic prostate cancer after castration;Smaletz;J Clin Oncol,2002

2. Prognostic model for predicting survival in men with hormone-refractory metastatic prostate cancer;Halabi;J Clin Oncol,2003

3. A contemporary prognostic nomogram for men with hormone-refractory metastatic prostate cancer: a TAX327 study analysis;Armstrong;Clin Cancer Res,2007

4. Prognostic model predicting metastatic castration-resistant prostate cancer survival in men treated with second-line chemotherapy;Halabi;J Natl Cancer Inst,2013

5. Updated prognostic model for predicting overall survival in first-line chemotherapy for patients with metastatic castration-resistant prostate cancer;Halabi;J Clin Oncol,2014

Cited by 135 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive and Prognostic 18F-Fluorocholine PET/CT Radiomics Nomogram in Patients with Castration-Resistant Prostate Cancer with Bone Metastases Treated with 223Ra;Cancers;2024-07-29

2. Tumor biomarkers for diagnosis, prognosis and targeted therapy;Signal Transduction and Targeted Therapy;2024-05-20

3. Outcomes and patterns of use of Radium-223 in metastatic castration-resistant prostate cancer;Frontiers in Oncology;2024-05-07

4. Increase of prostate-specific antigen doubling time predicts survival in metastatic castration-resistant prostate cancer patients undergoing radium therapy;Annals of Nuclear Medicine;2024-04-22

5. Evaluation of two-dimensional total bone uptake (2D-TBU) and bone scan index (BSI) extracted from active bone metastatic burden on the bone scintigraphy in patients with radium-223 treatment;Annals of Nuclear Medicine;2024-03-22